title: Severe pulmonary complications after bortezomib treatment in multiple myeloma.
authors.forename: Xiaoyi
authors.initials: X
authors.lastname: Dun
authors.forename: Zhengang
authors.initials: Z
authors.lastname: Yuan
authors.forename: Weijun
authors.initials: W
authors.lastname: Fu
authors.forename: Chunyang
authors.initials: C
authors.lastname: Zhang
authors.forename: Jian
authors.initials: J
authors.lastname: Hou
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000970:Antineoplastic Agents / Q000009:adverse effects*; D001897:Boronic Acids / Q000009:adverse effects*; D000069286:Bortezomib; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009101:Multiple Myeloma / Q000188:drug therapy*; D011379:Prognosis; D011719:Pyrazines / Q000009:adverse effects*; D012131:Respiratory Insufficiency / Q000139:chemically induced*; D015996:Survival Rate
chemical_list: D000970:Antineoplastic Agents; D001897:Boronic Acids; D011719:Pyrazines; D000069286:Bortezomib